Science


Windows Store will have iTunes by year-end

A handful of new features will try to bridge the gaps between Windows 10 and devices running iOS and Android. Build 16193 introduces some of the new features that Terry Myerson announced on stage at Build, including the new Story Remix app and Power Throttling.


Lighthouse Is An AI-Powered Home Security Camera

Lighthouse Is An AI-Powered Home Security Camera

If you ask, " What did the kids do while I was out today?" the app can pull up the last video the camera shot of your kids. You can decide whether you want to be alerted when the kids come home, if no one enters the kitchen, and more. The Lighthouse service stores video data for 30 days, and only keeps video that includes something moving, Teichman says. User information is only viewable by the users themselves, although if there was a legal law enforcement request, Lighthouse would be ...



Microsoft aiming to improve Windows 10

It will be available for iOS in the next few months, Microsoft said. Fluent Design System will also be replacing Microsoft's current Metro UI, and will be applied across Microsoft's other apps and services on Windows, Android and iOS.


Google Maps uses Street View to keep you on the right path

Google Maps uses Street View to keep you on the right path

The APK is signed by Google and upgrades your existing app. Street View mobile ready is designed for cameras that can publish to Street View directly from a mobile app with no desktop needed; Auto ready is for cameras tailored for vehicle-based capture; VR ready cameras must collect geometry data as well as generating sets of connected 360 photos; and Workflow ready cameras just need to support the ability to upload to Street View accounts from their publishing tools.



Trudeau Government Says Tillerson On Board With Climate Change

Adding pressure on the Trump administration, scientists from the United States and other Arctic nations issued a report ahead of the meeting warning that warming in the region could lead to trillions of dollars worth of damage to buildings, roads and other infrastructure this century.


Roche's Tecentriq fails to boost survival in bladder cancer study

Roche's Tecentriq fails to boost survival in bladder cancer study

Roche's Tecentriq wasn't supposed to fail its phase 3 trial in second-line bladder cancer . The FDA granted Tecentriq a first-line approval in bladder cancer , while both Bristol-Myers' Opdivo (nivolumab) and AstraZeneca's Imfinzi (durvalumab) only have second-line indications.